UniProt/SwissProt ID: | TNR6_HUMAN |
Description: | Fas (TNF receptor superfamily, member 6) [Source:HGNC Symbol;Acc:11920] |
Location: | chr10 q23.31 |
Node attribute: | PPI(source); PPI(target); receptor; gene |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S212 | QGSHEsPTLNP | HPRD; phosphoELM | |
S212 | QGSHEsPTLNP | Peptidase_M73 | PhosphoSitePlus |
S188 | KENQGsHESPT | HPRD | |
T193 | SHESPtLNPET | HPRD | |
S322 | DITSDsENSNF | Peptidase_M73 | PhosphoSitePlus |
Y232 | VDLSKyITTIA | Death; Peptidase_M73 | PhosphoSitePlus |
T214 | SHESPtLNPET | HPRD; phosphoELM | |
Y232 | VDLSKyITTIA | phosphoELM | |
T219 | TLNPEtVAINL | HPRD; phosphoELM | |
S209 | KENQGsHESPT | Peptidase_M73 | PhosphoSitePlus |
T241 | IAGVMtLSQVK | Death; Peptidase_M73 | PhosphoSitePlus |
S209 | KENQGsHESPT | HPRD; phosphoELM | |
Y91 | QEGKEyTDKAH | phosphoELM | |
Y91 | QEGKEyTDKAH | TNFR_c6 | PhosphoSitePlus |
Y291 | GKKEAyDTLIK | phosphoELM | |
T234 | LSKYItTIAGV | Death; Peptidase_M73 | PhosphoSitePlus |
S191 | QGSHEsPTLNP | HPRD | |
S243 | GVMTLsQVKGF | Death; Peptidase_M73 | PhosphoSitePlus |
T219 | TLNPEtVAINL | Peptidase_M73 | PhosphoSitePlus |
S325 | SDSENsNFRNE | Peptidase_M73 | PhosphoSitePlus |
Y291 | GKKEAyDTLIK | Death; Peptidase_M73 | PhosphoSitePlus |
T198 | TLNPEtVAINL | HPRD | |
Dephosphorylation site |
TNR6_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000347979 | L180F | HPI | Lymphoma | 9787134 |
ENSP00000347979 | N255D | HPI | Neoplasms by Histologic Type | 10620127 |
ENSP00000425159 | *150L | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000347979 | E211* | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000347979 | L278F | HPI | Lymphoma | 9787134 |
ENSP00000347979 | D269N | COSMIC | Head and Neck Cancer | |
ENSP00000347979 | A25T | HPI | Lymphoma | 9787134 |
ENSP00000347979 | P183L | HPI | Lymphoma | 9787134 |
ENSP00000347979 | C178R | HPI | Neoplasms by Histologic Type | 10620127 |
ENSP00000347979 | N264K | HPI | Lymphoma | 9787134 |
ENSP00000422453 | *133K | COSMIC | Melanoma | 21499247 |
ENSP00000347979 | N118S | HPI | Neoplasms by Histologic Type | 10620127 |
ENSP00000347979 | T198I | HPI | Lymphoma | 9787134 |
ENSP00000423755 | *150L | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000347979 | K299N | HPI | Lymphoma | 9787134 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000347979 | Uterine Cancer | Treatment(none vs. 5-Fluorouracil treatment) | cell line | Up | 15585135 | |
Hyperphosphorylation site |
TNR6_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
TNFL6_HUMAN | TNR6_HUMAN | ligand -> receptor | HPMR |
TNFL6_HUMAN | TNR6_HUMAN | other | KEGG |
TNR6_HUMAN | DAXX_HUMAN | other | KEGG |
TNR6_HUMAN | FADD_HUMAN | other | KEGG |
P53_HUMAN | TNR6_HUMAN | TF -> target gene | KEGG |
SP1_HUMAN | TNR6_HUMAN | TF -> target gene | TRANSFAC |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05010 | Alzheimer's disease |
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04210 | Apoptosis |
hsa05162 | Measles |
hsa05142 | Chagas disease (American trypanosomiasis) |
hsa05143 | African trypanosomiasis |
hsa05168 | Herpes simplex infection |
hsa05332 | Graft-versus-host disease |
hsa05330 | Allograft rejection |
hsa04010 | MAPK signaling pathway |
hsa05200 | Pathways in cancer |
hsa04940 | Type I diabetes mellitus |
hsa04115 | p53 signaling pathway |
hsa05164 | Influenza A |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa05320 | Autoimmune thyroid disease |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0005576 | extracellular region | IEA | cellular_component |
GO:0006919 | activation of cysteine-type endopeptidase activity | TAS | biological_process |
GO:0045121 | membrane raft | IDA | cellular_component |
GO:0031265 | CD95 death-inducing signaling complex | IDA | cellular_component |
GO:0071285 | cellular response to lithium ion | IEA | biological_process |
GO:0006927 | transformed cell apoptotic process | IEA | biological_process |
GO:0042981 | regulation of apoptotic process | NAS | biological_process |
GO:0051402 | neuron apoptotic process | IEA | biological_process |
GO:0019724 | B cell mediated immunity | IEA | biological_process |
GO:0019900 | kinase binding | IPI | molecular_function |
GO:0007165 | signal transduction | TAS | biological_process |
GO:0031265 | CD95 death-inducing signaling complex | IEA | cellular_component |
GO:0009636 | response to toxin | IEA | biological_process |
GO:0006917 | induction of apoptosis | TAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0032464 | positive regulation of protein homooligomerization | IEA | biological_process |
GO:0045619 | regulation of lymphocyte differentiation | IEA | biological_process |
GO:0048536 | spleen development | IEA | biological_process |
GO:0006461 | protein complex assembly | TAS | biological_process |
GO:0043066 | negative regulation of apoptotic process | IEA | biological_process |
GO:0004871 | signal transducer activity | TAS | molecular_function |
GO:0043029 | T cell homeostasis | IEA | biological_process |
GO:0002377 | immunoglobulin production | IEA | biological_process |
GO:0050869 | negative regulation of B cell activation | IEA | biological_process |
GO:0006915 | apoptotic process | IDA | biological_process |
GO:0071455 | cellular response to hyperoxia | IMP | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0004888 | transmembrane signaling receptor activity | IEA | molecular_function |
GO:0051384 | response to glucocorticoid stimulus | IEA | biological_process |
GO:0006924 | activation-induced cell death of T cells | IEA | biological_process |
GO:0010940 | positive regulation of necrotic cell death | IMP | biological_process |
GO:0045637 | regulation of myeloid cell differentiation | IEA | biological_process |
GO:0006915 | apoptotic process | IEA | biological_process |
GO:0016021 | integral to membrane | IEA | cellular_component |
GO:0043065 | positive regulation of apoptotic process | IMP | biological_process |
GO:0008625 | extrinsic apoptotic signaling pathway via death do | IEA | biological_process |
GO:0009897 | external side of plasma membrane | IEA | cellular_component |
GO:0042802 | identical protein binding | IPI | molecular_function |
GO:0031264 | death-inducing signaling complex | IDA | cellular_component |
GO:0006925 | inflammatory cell apoptotic process | IEA | biological_process |
GO:0043065 | positive regulation of apoptotic process | IEA | biological_process |
GO:0009986 | cell surface | IEA | cellular_component |
GO:0005886 | plasma membrane | IDA | cellular_component |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0003014 | renal system process | IEA | biological_process |
GO:0005829 | cytosol | NAS | cellular_component |
GO:0010467 | gene expression | IEA | biological_process |
GO:0004872 | receptor activity | NAS | molecular_function |
GO:0045060 | negative thymic T cell selection | IEA | biological_process |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0051260 | protein homooligomerization | IEA | biological_process |
GO:0071260 | cellular response to mechanical stimulus | IEP | biological_process |